Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Johnson & Johnson (JNJ) stock gains as Morgan Stanley upgrades the company to Overweight, lifting the price target to $262, ...

JNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures.

In the last six months Pfizer’s stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and J&J (NYSE: JNJ) primarily due to ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...

Johnson & Johnson’s post-Kenvue shift boosts growth and free cash flow, with an elite balance sheet but mixed revisions.

After a strong performance in 2025, Johnson & Johnson is starting the new year right.

Johnson & Johnson has just undergone its most significant transformation in decades. In 2023, the consumer health segment was spun off as Kenvue. Now, the orthopedic division is set to be separated as ...